|Funding for:||EU Students|
|Funding amount:||ARC £27,053|
|Placed On:||4th October 2018|
|Closes:||26th October 2018|
The Innovative Therapeutics Lab (University of Edinburgh) is looking for two Early Stage Researchers (PhD students) to carry out a project at the interface of bioorthogonal catalysis and medicinal chemistry. The project will build on previous success in the development and bio-independent release of caged drugs and probes with catalyst-loaded devices (Refs 1-4). The research will be carried out in the framework of the Marie Sklodowska-Curie European Training Network THERACAT (H2020-MSCA-ITN-2017, Project 765497), which has the objective to train a new generation of early stage researchers on new catalysis-based cancer therapies. The project would suit students with general interests in chemical biology, metal catalysis, medicinal chemistry and translational research.
Requirements for candidates:
Candidates should hold or expect to obtain a first-class honours degree (or a upper-second class with industry experience) in Chemistry, Pharmaceutical Sciences or a related discipline. Lab experience in organic synthesis, metal catalysis and/or medicinal chemistry via honours project, a year in industry or MSc by Research will be highly valued. The candidate will need to submit a cover letter and a 2-page CV including the details of two reference contacts to Asier.Unciti-Broceta@igmm.ed.ac.uk
Marie-Curie fellowship Mobility requirement:
To be eligible for the position you may NOT have been resident in the UK for more than 12 months in the past three years and may have a maximum of four years full-time equivalent research experience and not have been awarded a doctoral degree.
For further information about the research of the host group and the supervisor, please see:
For more information and to submit an application, please use the ‘apply’ button above.
Type / Role: